Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Tadalafil (Adcirca) and tadalafil (Cialis) are both medications that belong to the PDE-5 inhibitor class and share the active ingredient tadalafil. They are used to treat different conditions. Tadalafil (Adcirca) is FDA-approved for pulmonary arterial hypertension (PAH), while tadalafil (Cialis) is approved for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). Tadalafil (Adcirca) is taken once daily, with a typical dose of 40 mg. Tadalafil (Cialis) can be taken as needed or daily for ED, with doses ranging from 2.5 mg to 20 mg. Tadalafil is availiable is available as tablets and an oral suspension. Common side effects for both include headache and muscle pain, but tadalafil (Adcirca) may also cause respiratory infections, while tadalafil (Cialis) can cause indigestion. Both medications can interact with nitrates and blood pressure medications, leading to dangerously low blood pressure. Both medications are available in a lower-cost generic form.
Tadalafil (Adcirca)
Tadalafil (Cialis)
Tadalafil (Adcirca)
Tadalafil (Cialis)
Summary of Adcirca vs. Cialis
Summary for PDE-5 inhibitor
Prescription only
Tadalafil (Adcirca) is a phosphodiesterase 5 (PDE-5) blocker. It's used to improve exercise ability in adults who have high blood pressure in the lungs, also known as pulmonary arterial hypertension (PAH). It's taken by mouth once daily. Tadalafil for PAH is available as tablets (Adcirca, Alyq) and an oral suspension (Tadliq). Side effects of tadalafil (Adcirca) are typically mild and temporary, and can include headache and muscle pain.